191 related articles for article (PubMed ID: 18981011)
1. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Sandanaraj E; Lal S; Selvarajan V; Ooi LL; Wong ZW; Wong NS; Ang PC; Lee EJ; Chowbay B
Clin Cancer Res; 2008 Nov; 14(21):7116-26. PubMed ID: 18981011
[TBL] [Abstract][Full Text] [Related]
2. SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.
Singh O; Chan JY; Lin K; Heng CC; Chowbay B
PLoS One; 2012; 7(12):e51771. PubMed ID: 23272163
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pregnane X Receptor
Yuan JJ; Ma XJ; Li ZS; Chang YZ; Zhang W; Kan QC; Hou JK; Zhang LR
BMC Med Genet; 2016 Nov; 17(1):87. PubMed ID: 27876007
[TBL] [Abstract][Full Text] [Related]
4. PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
Hor SY; Lee SC; Wong CI; Lim YW; Lim RC; Wang LZ; Fan L; Guo JY; Lee HS; Goh BC; Tan T
Pharmacogenomics J; 2008 Apr; 8(2):139-46. PubMed ID: 17876342
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance.
Schipani A; Siccardi M; D'Avolio A; Baietto L; Simiele M; Bonora S; Rodríguez Novoa S; Cuenca L; Soriano V; Chierakul N; Saguenwong N; Chuchuttaworn C; Hoskins JM; Dvorak AM; McLeod HL; Davies G; Khoo S; Back DJ; Di Perri G; Owen A
Antimicrob Agents Chemother; 2010 Dec; 54(12):5242-50. PubMed ID: 20921307
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy.
Haerian BS; Lim KS; Mohamed EH; Tan HJ; Tan CT; Raymond AA; Wong CP; Wong SW; Mohamed Z
Seizure; 2011 Jun; 20(5):387-94. PubMed ID: 21316268
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.
Lal S; Sutiman N; Ooi LL; Wong ZW; Wong NS; Ang PCS; Chowbay B
Pharmacogenomics J; 2017 Jul; 17(4):337-343. PubMed ID: 26975227
[TBL] [Abstract][Full Text] [Related]
8. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
Gupta A; Mugundu GM; Desai PB; Thummel KE; Unadkat JD
Drug Metab Dispos; 2008 Jun; 36(6):1172-80. PubMed ID: 18332086
[TBL] [Abstract][Full Text] [Related]
9. The effects of splicing variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA expressions.
Liu Y; Ji W; Yin Y; Fan L; Zhang J; Yun H; Wang N; Li Q; Wei Z; Ouyang D; Zhou HH
Clin Chim Acta; 2009 May; 403(1-2):142-4. PubMed ID: 19232333
[TBL] [Abstract][Full Text] [Related]
10. Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients.
Lal S; Wong ZW; Sandanaraj E; Xiang X; Ang PC; Lee EJ; Chowbay B
Cancer Sci; 2008 Apr; 99(4):816-23. PubMed ID: 18377430
[TBL] [Abstract][Full Text] [Related]
11. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
Cho JH; Yoon YD; Park JY; Song EJ; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591
[TBL] [Abstract][Full Text] [Related]
12. Genetic predictors of interindividual variability in hepatic CYP3A4 expression.
Lamba V; Panetta JC; Strom S; Schuetz EG
J Pharmacol Exp Ther; 2010 Mar; 332(3):1088-99. PubMed ID: 19934400
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.
Liu CL; Lim YP; Hu ML
Mar Drugs; 2012 Jan; 10(1):242-257. PubMed ID: 22363234
[TBL] [Abstract][Full Text] [Related]
14. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.
Shi XJ; Geng F; Jiao Z; Cui XY; Qiu XY; Zhong MK
J Clin Pharm Ther; 2011 Oct; 36(5):614-24. PubMed ID: 21916909
[TBL] [Abstract][Full Text] [Related]
15. Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.
Oleson L; von Moltke LL; Greenblatt DJ; Court MH
Xenobiotica; 2010 Feb; 40(2):146-62. PubMed ID: 20082578
[TBL] [Abstract][Full Text] [Related]
16. No correlation of hsa-miR-148a with expression of PXR or CYP3A4 in human livers from Chinese Han population.
Wei Z; Chen M; Zhang Y; Wang X; Jiang S; Wang Y; Wu X; Qin S; He L; Zhang L; Xing Q
PLoS One; 2013; 8(3):e59141. PubMed ID: 23527115
[TBL] [Abstract][Full Text] [Related]
17. Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation.
Nakagawa J; Kinjo T; Aiuchi N; Ueno K; Tomita H; Niioka T
Eur J Clin Pharmacol; 2023 Jan; 79(1):127-135. PubMed ID: 36399204
[TBL] [Abstract][Full Text] [Related]
18. Identification of NR1I2 genetic variation using resequencing.
King CR; Xiao M; Yu J; Minton MR; Addleman NJ; Van Booven DJ; Kwok PY; McLeod HL; Marsh S
Eur J Clin Pharmacol; 2007 Jun; 63(6):547-54. PubMed ID: 17404718
[TBL] [Abstract][Full Text] [Related]
19. Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.
Voon PJ; Yap HL; Ma CY; Lu F; Wong AL; Sapari NS; Soong R; Soh TI; Goh BC; Lee HS; Lee SC
Br J Clin Pharmacol; 2013 Jun; 75(6):1497-505. PubMed ID: 23116553
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
